Drug Trial Radar · NCT05264506
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
Last checked: Nov 19, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3,055
Actual
Start
Feb 17, 2022
Primary completion
Jan 12, 2024
Study completion Jan 26, 2024
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- Mar 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 14 years, up to 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is evaluating Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive in Premenopausal Females Aged 14 to 35 Years (Inclusive).
Conditions
- Contraception
Interventions
NOMAC-E2 COCDrug
Dosage Formulation: Film-coated Tablet Unit Dose Strength: Nomegestrol acetate (NOMAC) 2.5 mg and estradiol (E2) 1.5 mg; Each blister strip contains 28 tablets: 24 tablets with the active drug (number 1 to 24) and 4 tablets with placebo (number 25 to 28). Dosing Instructions: oral. Take 1 tablet daily at about the same time as directed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With On-treatment PregnanciesTime frame: 1 year
Locations
103 sites in 1 country. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
SEC Clinical Research
Dothan, Alabama
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Velocity Clinical Research
Mobile, Alabama
Mesa Obstetricians and Gynecologists
Mesa, Arizona
Desert Clinical Research, LLC/CCT Research
Mesa, Arizona
Velocity Clinical Research - Phoenix
Phoenix, Arizona
Precision Trials AZ, LLC
Phoenix, Arizona
Alliance for Multispecialty Research
Tempe, Arizona
Noble Clinical Research
Tucson, Arizona
Eclipse Clinical Research
Tucson, Arizona
Gardens Medical Center / Alliance Research Institute
Bell Gardens, California
Alliance Research Institute, LLC
Canoga Park, California
Advanced Investigative Medicine, Inc
Hawthorne, California
Marvel Clinical Research
Huntington Beach, California
Om Research LLC
Lancaster, California
Empire Clinical Research
Pomona, California
WR-Women's Health Care Research, LLC
San Diego, California
WR-Medical Center For Clinical Research - San Diego
San Diego, California
Velocity Clinical Research
Denver, Colorado
Physicians' Research Options / Red Rocks OB/GYN
Lakewood, Colorado
CMR of Greater New Haven, LLC
Hamden, Connecticut
Alliance for Multispecialty Research, LLC
Coral Gables, Florida
Universal Axon Clinical Research, LLC
Doral, Florida
Alliance for Multispecialty Research, LLC
Fort Myers, Florida
Altus Research, Inc.
Lake Worth, Florida
Accel Research Sites - St. Petersburg Clinical Research Unit
Largo, Florida
OB-GYN Associates of Mid-Florida, PA
Leesburg, Florida
Avantis Clinical Research, LLC
Miami, Florida
Miami Clinical Research
Miami, Florida
Admed Research, LLC
Miami, Florida
Genoma Research Group, Inc.
Miami, Florida
Spotlight Research Center, LLC
Miami, Florida
New Age Medical Research Corporation
Miami, Florida
Quantum Clinical Trials
Miami Beach, Florida
Quality Research of South Florida
Miami Lakes, Florida
Healthcare Clinical Data, Inc.
North Miami, Florida
Sensible Healthcare LLC
Ocoee, Florida
Innovation Medical Research Center
Palmetto Bay, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Showing 40 of 103 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.